Artificial ovary
US-2017369851-A1 · Dec 28, 2017 · US
Compositions for autologous ovarian oogonial stem cell mitochondrial energy transfer
US9150830B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9150830-B2 |
| Application number | US-201213606914-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 7, 2012 |
| Priority date | Apr 14, 2011 |
| Publication date | Oct 6, 2015 |
| Grant date | Oct 6, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Oogonial stem cell (OSC)-derived compositions, such as nuclear free cytoplasm or isolated mitochondria, and uses of OSC-derived compositions in autologous fertility-enhancing procedures are described.
First claim
Opening claim text (preview).
What is claimed is: 1. A composition comprising i) functional mitochondria obtained from an ovarian oogonial stem cell (OSC) or the progeny of an ovarian OSC, wherein the OSC is a non-embryonic stem cell that is mitotically competent and expresses Vasa, Oct-4, Dazl, Stella, and optionally, a stage-specific embryonic antigen and ii) a fluorescent mitochondrial tracking probe bound to the functional mitochondria. 2. The composition of claim 1 , wherein the track…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9150830B2 cover?
- Oogonial stem cell (OSC)-derived compositions, such as nuclear free cytoplasm or isolated mitochondria, and uses of OSC-derived compositions in autologous fertility-enhancing procedures are described.
- Who is the assignee on this patent?
- Tilly Jonathan L, Woods Dori C, Gen Hospital Corp
- What technology area does this patent fall under?
- Primary CPC classification C12N5/0609. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).